Article
Delta power robustly predicts cognitive function in Angelman syndrome
28 May 2021
Abstract excerpt
OBJECTIVE: Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by loss of function of the maternally inherited UBE3A gene in neurons. Promising disease-modifying treatments to reinstate UBE3A expression are under development and an early measure of treatment response is critical to their deployment in clinical trials. Increased delta power in EEG recordings, reflecting abnormal neuronal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
